Preload Image
Preload Image
Report Store mobile icon
Global Typhoid Vaccine Market Growth 2024-2030

Global Typhoid Vaccine Market Growth 2024-2030

2024

Global Typhoid Vaccine Market Growth 2024-2030

The global typhoid vaccine market is valued at US$ 11.64 billion in 2024, with growing demand for vaccines in emerging economies.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global typhoid vaccine market is experiencing significant growth as the demand for effective immunization solutions rises due to increasing cases of typhoid fever in developing regions, as well as the growing awareness surrounding the importance of vaccination in preventing infectious diseases. Typhoid fever, caused by the bacterium Salmonella enterica serotype Typhi, remains a major health concern, particularly in low- and middle-income countries where sanitation and access to clean drinking water are often limited. According to the World Health Organization (WHO), the global incidence of typhoid fever remains high, with an estimated 11–20 million cases and approximately 128,000 to 161,000 deaths annually. This highlights the need for widespread vaccination as a preventive measure. With the ongoing efforts to reduce the burden of infectious diseases and prevent outbreaks, the typhoid vaccine market has gained traction, driven by governmental initiatives, NGOs, and healthcare organizations pushing for the availability of vaccines in endemic regions. As global vaccination programs expand, the market for typhoid vaccines is expected to continue its upward trajectory. Additionally, the growing focus on immunization in countries aiming to achieve global health targets, such as the United Nations' Sustainable Development Goals, has further spurred the demand for vaccines, including those targeting typhoid fever. Moreover, the recent advancements in vaccine development, including the introduction of new generation vaccines that offer improved safety profiles and efficacy, have contributed to the market's growth. The increasing availability of vaccines in both urban and rural areas, coupled with more affordable vaccine options, is expected to play a pivotal role in reducing the incidence of typhoid fever and driving the overall growth of the market.

According to Publisher, , the global Typhoid Vaccine market size was valued at US$ 11640 million in 2024. With growing demand in downstream market, the Typhoid Vaccine is forecast to a readjusted size of US$ 15370 million by 2030 with a CAGR of 4.0% during review period. The market for typhoid vaccines is influenced by various factors, including vaccine type, application, and region-specific needs. The primary types of typhoid vaccines are the injectable Vi polysaccharide vaccine (ViPS) and the oral live attenuated vaccine, Ty21a. The ViPS vaccine is widely used for adults and children above two years of age and provides protection against the Salmonella bacteria. It is administered through a single injection and is considered one of the most effective vaccines available for preventing typhoid fever. The oral Ty21a vaccine, on the other hand, is recommended for travelers to regions with endemic typhoid and for those living in high-risk areas. This vaccine consists of a series of capsules taken over several days and offers immunity by stimulating the body’s immune response. Both vaccines have demonstrated high efficacy in preventing typhoid fever and are used in different settings, depending on the specific health needs of the population. However, there is an increasing push for the development of newer, more effective vaccines that offer longer-lasting protection, require fewer doses, and are more affordable. Recent advancements in vaccine development have led to the introduction of conjugate vaccines, which combine the Vi antigen with a carrier protein to boost immune responses. These conjugate vaccines are more effective in younger children and offer longer-lasting immunity, making them a promising solution for endemic regions. As vaccine research continues to progress, the availability of improved vaccines with enhanced safety profiles and greater efficacy is expected to shape the future of the global typhoid vaccine market, helping to curb the spread of typhoid fever and reduce its impact on public health worldwide.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


In terms of application, the typhoid vaccine market is primarily driven by the increasing demand for preventive healthcare measures in regions with high rates of typhoid fever. Governments and international health organizations have launched immunization campaigns to curb the spread of the disease, particularly in low-income countries where sanitation and hygiene practices are inadequate. For instance, in India and several other countries in Southeast Asia and sub-Saharan Africa, typhoid fever remains a leading cause of morbidity and mortality. In these regions, mass vaccination campaigns targeting high-risk populations, such as children, are being implemented to reduce the incidence of typhoid fever. The widespread adoption of typhoid vaccines in these regions is expected to play a crucial role in achieving disease elimination targets set by health authorities. In addition to mass immunization programs, the increasing number of travelers to endemic regions has also contributed to the demand for typhoid vaccines. Vaccination requirements for travelers are becoming more stringent, especially for those planning to visit countries with high rates of typhoid fever. As a result, the global market for typhoid vaccines is growing as both endemic and non-endemic countries seek to protect their populations from the disease. Furthermore, the growing awareness of the importance of vaccination and the push for universal health coverage are expected to enhance the uptake of typhoid vaccines. In the coming years, the continued integration of vaccination programs into routine healthcare services, combined with government initiatives aimed at increasing vaccine accessibility, will drive further growth in the typhoid vaccine market, ultimately contributing to the global reduction of typhoid fever cases.

The global typhoid vaccine market is also segmented by region, with significant variations in demand based on the prevalence of typhoid fever, healthcare infrastructure, and economic factors. In regions such as South Asia, Sub-Saharan Africa, and parts of Latin America, where typhoid fever is endemic, the demand for vaccines is notably high. Countries such as India, Pakistan, Bangladesh, and Nepal experience a substantial burden of typhoid fever, primarily due to the lack of access to safe drinking water, inadequate sanitation facilities, and overpopulation. These regions rely heavily on both international organizations and governmental efforts to address the issue through mass vaccination programs. Additionally, the availability of affordable vaccines, along with the deployment of immunization campaigns in rural areas, is expected to accelerate the growth of the typhoid vaccine market in these regions. On the other hand, the demand for typhoid vaccines is comparatively lower in developed regions such as North America and Europe, where the incidence of typhoid fever is relatively low due to better sanitation, improved healthcare systems, and access to clean water. However, in these regions, vaccination is still recommended for travelers to endemic areas, which contributes to the demand for vaccines. The ongoing research and development of new vaccines and delivery systems are expected to improve vaccine accessibility, especially in low-income countries. In addition to government-led vaccination initiatives, the private sector and international organizations are increasingly involved in ensuring the availability of vaccines in areas with limited healthcare infrastructure. As global health organizations continue to support vaccination efforts, the global typhoid vaccine market is poised for steady growth, helping to reduce the global burden of typhoid fever and improving overall public health outcomes.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Typhoid Vaccine Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Typhoid Vaccine by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Typhoid Vaccine by Country/Region, 2019, 2023 & 2030
  • 2.2 Typhoid Vaccine Segment by Type
  • 2.2.1 Oral Type Typhoid Vaccine
  • 2.2.2 Injection Type Typhoid Vaccine
  • 2.3 Typhoid Vaccine Sales by Type
  • 2.3.1 Global Typhoid Vaccine Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Typhoid Vaccine Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Typhoid Vaccine Sale Price by Type (2019-2024)
  • 2.4 Typhoid Vaccine Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Research & Academic Laboratories
  • 2.4.3 Pharmaceutical & Biotechnology Companies
  • 2.4.4 Others
  • 2.5 Typhoid Vaccine Sales by Application
  • 2.5.1 Global Typhoid Vaccine Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Typhoid Vaccine Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Typhoid Vaccine Sale Price by Application (2019-2024)
  • 3 Global Typhoid Vaccine by Company
  • 3.1 Global Typhoid Vaccine Breakdown Data by Company
  • 3.1.1 Global Typhoid Vaccine Annual Sales by Company (2019-2024)
  • 3.1.2 Global Typhoid Vaccine Sales Market Share by Company (2019-2024)
  • 3.2 Global Typhoid Vaccine Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Typhoid Vaccine Revenue by Company (2019-2024)
  • 3.2.2 Global Typhoid Vaccine Revenue Market Share by Company (2019-2024)
  • 3.3 Global Typhoid Vaccine Sale Price by Company
  • 3.4 Key Manufacturers Typhoid Vaccine Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Typhoid Vaccine Product Location Distribution
  • 3.4.2 Players Typhoid Vaccine Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Typhoid Vaccine by Geographic Region
  • 4.1 World Historic Typhoid Vaccine Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Typhoid Vaccine Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Typhoid Vaccine Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Typhoid Vaccine Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Typhoid Vaccine Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Typhoid Vaccine Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Typhoid Vaccine Sales Growth
  • 4.4 APAC Typhoid Vaccine Sales Growth
  • 4.5 Europe Typhoid Vaccine Sales Growth
  • 4.6 Middle East & Africa Typhoid Vaccine Sales Growth
  • 5 Americas
  • 5.1 Americas Typhoid Vaccine Sales by Country
  • 5.1.1 Americas Typhoid Vaccine Sales by Country (2019-2024)
  • 5.1.2 Americas Typhoid Vaccine Revenue by Country (2019-2024)
  • 5.2 Americas Typhoid Vaccine Sales by Type
  • 5.3 Americas Typhoid Vaccine Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Typhoid Vaccine Sales by Region
  • 6.1.1 APAC Typhoid Vaccine Sales by Region (2019-2024)
  • 6.1.2 APAC Typhoid Vaccine Revenue by Region (2019-2024)
  • 6.2 APAC Typhoid Vaccine Sales by Type
  • 6.3 APAC Typhoid Vaccine Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Typhoid Vaccine by Country
  • 7.1.1 Europe Typhoid Vaccine Sales by Country (2019-2024)
  • 7.1.2 Europe Typhoid Vaccine Revenue by Country (2019-2024)
  • 7.2 Europe Typhoid Vaccine Sales by Type
  • 7.3 Europe Typhoid Vaccine Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Typhoid Vaccine by Country
  • 8.1.1 Middle East & Africa Typhoid Vaccine Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Typhoid Vaccine Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Typhoid Vaccine Sales by Type
  • 8.3 Middle East & Africa Typhoid Vaccine Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Typhoid Vaccine
  • 10.3 Manufacturing Process Analysis of Typhoid Vaccine
  • 10.4 Industry Chain Structure of Typhoid Vaccine
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Typhoid Vaccine Distributors
  • 11.3 Typhoid Vaccine Customer
  • 12 World Forecast Review for Typhoid Vaccine by Geographic Region
  • 12.1 Global Typhoid Vaccine Market Size Forecast by Region
  • 12.1.1 Global Typhoid Vaccine Forecast by Region (2025-2030)
  • 12.1.2 Global Typhoid Vaccine Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Typhoid Vaccine Forecast by Type
  • 12.7 Global Typhoid Vaccine Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Sanofi
  • 13.1.1 Sanofi Company Information
  • 13.1.2 Sanofi Typhoid Vaccine Product Portfolios and Specifications
  • 13.1.3 Sanofi Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Sanofi Main Business Overview
  • 13.1.5 Sanofi Latest Developments
  • 13.2 Merck
  • 13.2.1 Merck Company Information
  • 13.2.2 Merck Typhoid Vaccine Product Portfolios and Specifications
  • 13.2.3 Merck Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Merck Main Business Overview
  • 13.2.5 Merck Latest Developments
  • 13.3 GlaxoSmithKline
  • 13.3.1 GlaxoSmithKline Company Information
  • 13.3.2 GlaxoSmithKline Typhoid Vaccine Product Portfolios and Specifications
  • 13.3.3 GlaxoSmithKline Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 GlaxoSmithKline Main Business Overview
  • 13.3.5 GlaxoSmithKline Latest Developments
  • 13.4 PaxVax
  • 13.4.1 PaxVax Company Information
  • 13.4.2 PaxVax Typhoid Vaccine Product Portfolios and Specifications
  • 13.4.3 PaxVax Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 PaxVax Main Business Overview
  • 13.4.5 PaxVax Latest Developments
  • 13.5 Actiza Pharmaceutical
  • 13.5.1 Actiza Pharmaceutical Company Information
  • 13.5.2 Actiza Pharmaceutical Typhoid Vaccine Product Portfolios and Specifications
  • 13.5.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Actiza Pharmaceutical Main Business Overview
  • 13.5.5 Actiza Pharmaceutical Latest Developments
  • 13.6 Merit Pharmaceuticals
  • 13.6.1 Merit Pharmaceuticals Company Information
  • 13.6.2 Merit Pharmaceuticals Typhoid Vaccine Product Portfolios and Specifications
  • 13.6.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 Merit Pharmaceuticals Main Business Overview
  • 13.6.5 Merit Pharmaceuticals Latest Developments
  • 13.7 Bharat Biotec
  • 13.7.1 Bharat Biotec Company Information
  • 13.7.2 Bharat Biotec Typhoid Vaccine Product Portfolios and Specifications
  • 13.7.3 Bharat Biotec Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Bharat Biotec Main Business Overview
  • 13.7.5 Bharat Biotec Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Typhoid Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Typhoid Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oral Type Typhoid Vaccine
Table 4. Major Players of Injection Type Typhoid Vaccine
Table 5. Global Typhoid Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Typhoid Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Typhoid Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Typhoid Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Typhoid Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Typhoid Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Typhoid Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Typhoid Vaccine Revenue by Application (2019-2024)
Table 13. Global Typhoid Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Typhoid Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Typhoid Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Typhoid Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Typhoid Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Typhoid Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Typhoid Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Typhoid Vaccine Producing Area Distribution and Sales Area
Table 21. Players Typhoid Vaccine Products Offered
Table 22. Typhoid Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Typhoid Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Typhoid Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Typhoid Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Typhoid Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Typhoid Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Typhoid Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Typhoid Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Typhoid Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Typhoid Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Typhoid Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Typhoid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Typhoid Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Typhoid Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Typhoid Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Typhoid Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Typhoid Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Typhoid Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Typhoid Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Typhoid Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Typhoid Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Typhoid Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Typhoid Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Typhoid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Typhoid Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Typhoid Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Typhoid Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Typhoid Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Typhoid Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Typhoid Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Typhoid Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Typhoid Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Typhoid Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Typhoid Vaccine
Table 58. Key Market Challenges & Risks of Typhoid Vaccine
Table 59. Key Industry Trends of Typhoid Vaccine
Table 60. Typhoid Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Typhoid Vaccine Distributors List
Table 63. Typhoid Vaccine Customer List
Table 64. Global Typhoid Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Typhoid Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Typhoid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Typhoid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Typhoid Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Typhoid Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Typhoid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Typhoid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Typhoid Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Typhoid Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Typhoid Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Typhoid Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Typhoid Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Typhoid Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Basic Information, Typhoid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Typhoid Vaccine Product Portfolios and Specifications
Table 80. Sanofi Typhoid Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Merck Basic Information, Typhoid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Typhoid Vaccine Product Portfolios and Specifications
Table 85. Merck Typhoid Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. GlaxoSmithKline Basic Information, Typhoid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GlaxoSmithKline Typhoid Vaccine Product Portfolios and Specifications
Table 90. GlaxoSmithKline Typhoid Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. GlaxoSmithKline Main Business
Table 92. GlaxoSmithKline Latest Developments
Table 93. PaxVax Basic Information, Typhoid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. PaxVax Typhoid Vaccine Product Portfolios and Specifications
Table 95. PaxVax Typhoid Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. PaxVax Main Business
Table 97. PaxVax Latest Developments
Table 98. Actiza Pharmaceutical Basic Information, Typhoid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Actiza Pharmaceutical Typhoid Vaccine Product Portfolios and Specifications
Table 100. Actiza Pharmaceutical Typhoid Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Actiza Pharmaceutical Main Business
Table 102. Actiza Pharmaceutical Latest Developments
Table 103. Merit Pharmaceuticals Basic Information, Typhoid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Merit Pharmaceuticals Typhoid Vaccine Product Portfolios and Specifications
Table 105. Merit Pharmaceuticals Typhoid Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Merit Pharmaceuticals Main Business
Table 107. Merit Pharmaceuticals Latest Developments
Table 108. Bharat Biotec Basic Information, Typhoid Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Bharat Biotec Typhoid Vaccine Product Portfolios and Specifications
Table 110. Bharat Biotec Typhoid Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Bharat Biotec Main Business
Table 112. Bharat Biotec Latest Developments
List of


Figure 1. Picture of Typhoid Vaccine
Figure 2. Typhoid Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Typhoid Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Typhoid Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Typhoid Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Oral Type Typhoid Vaccine
Figure 10. Product Picture of Injection Type Typhoid Vaccine
Figure 11. Global Typhoid Vaccine Sales Market Share by Type in 2023
Figure 12. Global Typhoid Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Typhoid Vaccine Consumed in Hospital
Figure 14. Global Typhoid Vaccine Market: Hospital (2019-2024) & (K Units)
Figure 15. Typhoid Vaccine Consumed in Research & Academic Laboratories
Figure 16. Global Typhoid Vaccine Market: Research & Academic Laboratories (2019-2024) & (K Units)
Figure 17. Typhoid Vaccine Consumed in Pharmaceutical & Biotechnology Companies
Figure 18. Global Typhoid Vaccine Market: Pharmaceutical & Biotechnology Companies (2019-2024) & (K Units)
Figure 19. Typhoid Vaccine Consumed in Others
Figure 20. Global Typhoid Vaccine Market: Others (2019-2024) & (K Units)
Figure 21. Global Typhoid Vaccine Sales Market Share by Application (2023)
Figure 22. Global Typhoid Vaccine Revenue Market Share by Application in 2023
Figure 23. Typhoid Vaccine Sales Market by Company in 2023 (K Units)
Figure 24. Global Typhoid Vaccine Sales Market Share by Company in 2023
Figure 25. Typhoid Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Typhoid Vaccine Revenue Market Share by Company in 2023
Figure 27. Global Typhoid Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Typhoid Vaccine Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Typhoid Vaccine Sales 2019-2024 (K Units)
Figure 30. Americas Typhoid Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. APAC Typhoid Vaccine Sales 2019-2024 (K Units)
Figure 32. APAC Typhoid Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Europe Typhoid Vaccine Sales 2019-2024 (K Units)
Figure 34. Europe Typhoid Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Typhoid Vaccine Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Typhoid Vaccine Revenue 2019-2024 ($ Millions)
Figure 37. Americas Typhoid Vaccine Sales Market Share by Country in 2023
Figure 38. Americas Typhoid Vaccine Revenue Market Share by Country in 2023
Figure 39. Americas Typhoid Vaccine Sales Market Share by Type (2019-2024)
Figure 40. Americas Typhoid Vaccine Sales Market Share by Application (2019-2024)
Figure 41. United States Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Typhoid Vaccine Sales Market Share by Region in 2023
Figure 46. APAC Typhoid Vaccine Revenue Market Share by Regions in 2023
Figure 47. APAC Typhoid Vaccine Sales Market Share by Type (2019-2024)
Figure 48. APAC Typhoid Vaccine Sales Market Share by Application (2019-2024)
Figure 49. China Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Typhoid Vaccine Sales Market Share by Country in 2023
Figure 57. Europe Typhoid Vaccine Revenue Market Share by Country in 2023
Figure 58. Europe Typhoid Vaccine Sales Market Share by Type (2019-2024)
Figure 59. Europe Typhoid Vaccine Sales Market Share by Application (2019-2024)
Figure 60. Germany Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Typhoid Vaccine Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Typhoid Vaccine Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Typhoid Vaccine Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Typhoid Vaccine Sales Market Share by Application (2019-2024)
Figure 69. Egypt Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Typhoid Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Typhoid Vaccine in 2023
Figure 75. Manufacturing Process Analysis of Typhoid Vaccine
Figure 76. Industry Chain Structure of Typhoid Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Typhoid Vaccine Sales Market Forecast by Region (2025-2030)
Figure 79. Global Typhoid Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Typhoid Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Typhoid Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Typhoid Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Typhoid Vaccine Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Typhoid Vaccine Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.